Incidence of Cerebral Venous Thrombosis Following SARS-CoV-2 Infection vs mRNA SARS-CoV-2 Vaccination in Singapore

Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients

(2021) Sharon Amit et al.   LANCET

Cerebral Venous Thrombosis in COVID-19: A New York Metropolitan Cohort Study

(2021) F. Al-Mufti et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Frequency of positive anti-PF4/polyanion antibody tests after COVID-19 vaccination with ChAdOx1 nCoV-19 and BNT162b2

(2021) Thomas Thiele et al.   BLOOD

US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021

(2021) Isaac See et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data

(2021) Eric J Haas et al.   LANCET

Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination

(2021) Kate-Lynn Muir et al.   NEW ENGLAND JOURNAL OF MEDICINE

Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination

(2021) Andreas Greinacher et al.   NEW ENGLAND JOURNAL OF MEDICINE

Venous thromboembolism in COVID-19: A systematic review and meta-analysis

(2021) Anastasios Kollias et al.   VASCULAR MEDICINE

Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study

(2021) Anton Pottegård et al.   BMJ-British Medical Journal

A global database of COVID-19 vaccinations

(2021) Edouard Mathieu et al.   Nature Human Behaviour

Acute Ischemic Stroke During the Convalescent Phase of Asymptomatic COVID-2019 Infection in Men

(2021) Tian Ming Tu et al.   JAMA Network Open

Thrombosis With Thrombocytopenia After the Messenger RNA–1273 Vaccine

(2021) Swathi Sangli et al.   ANNALS OF INTERNAL MEDICINE

SARS-CoV-2 Vaccine Effectiveness in a High-Risk National Population in a Real-World Setting

(2021) Adeel A. Butt et al.   ANNALS OF INTERNAL MEDICINE

Surveillance for Adverse Events After COVID-19 mRNA Vaccination

(2021) Nicola P. Klein et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Cerebral Venous Thrombosis after BNT162b2 mRNA SARS-CoV-2 vaccine

(2021) Leonor Dias et al.   Journal of Stroke & Cerebrovascular Diseases

Divergent vaccination policies could fuel mistrust and hesitancy

(2021) Rebecca Forman et al.   LANCET

Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study

(2021) Katherine A Twohig et al.   LANCET INFECTIOUS DISEASES

COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries

(2021) Julio S. Solís Arce et al.   NATURE MEDICINE

Myocardial Infarction, Stroke, and Pulmonary Embolism After BNT162b2 mRNA COVID-19 Vaccine in People Aged 75 Years or Older

(2021) Marie Joelle Jabagi et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Cerebral venous sinus thrombosis after mRNA-based COVID-19 vaccination

(2021) Yohsuke Yagi et al.   NEUROLOGICAL SCIENCES

Trends in incidence and epidemiologic characteristics of cerebral venous thrombosis in the United States

(2020) Fadar Oliver Otite et al.   NEUROLOGY

Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome

(2020) Maria Orietta Borghi et al.   Frontiers in Immunology

Cerebral Venous Thrombosis in Patients with COVID-19 Infection: a Case Series and Systematic Review

(2020) Tian Ming Tu et al.   Journal of Stroke & Cerebrovascular Diseases

Demographic shift in COVID-19 patients in Singapore from an aged, at-risk population to young migrant workers with reduced risk of severe disease

(2020) Jinghao Nicholas Ngiam et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Cerebral Venous Sinus Thrombosis Incidence Is Higher Than Previously Thought

(2016) Sharon Devasagayam et al.   STROKE

International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines

(2013) Caitlin N. Dodd et al.   VACCINE